Sorrento Therapeutics Announces $25 Million Registered Direct Offering
|
(Source: GlobeNewswire) antibody-centric biopharmaceutical company developing new therapies to … on the SEC’s website at www.sec.gov or by contacting H.C. Wainwright & Co., …
(Source: GlobeNewswire) antibody-centric biopharmaceutical company developing new therapies to … on the SEC’s website at www.sec.gov or by contacting H.C. Wainwright & Co., …